Natera, Inc. (NTRA)
NASDAQ: NTRA · Real-Time Price · USD
195.32
-8.89 (-4.35%)
At close: May 13, 2026, 4:00 PM EDT
196.13
+0.81 (0.41%)
After-hours: May 13, 2026, 7:36 PM EDT

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13
Insurance Carriers Revenue
2.36B2.17B1.57B
Insurance Carriers Revenue Growth
8.54%38.13%64.73%
Laboratory Partners Revenue
111.10M103.11M97.21M
Laboratory Partners Revenue Growth
7.74%6.07%-1.70%
Patients Revenue
33.20M31.82M27.88M
Patients Revenue Growth
4.36%14.10%-5.56%
Revenue (Other)
1,000.00-7.00K-4.00K
Revenue (Total)
2.50B2.31B1.70B
Revenue (Total) Growth
8.45%35.90%56.75%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13
United States Revenue
2.46B2.26B1.66B
United States Revenue Growth
8.54%36.59%58.24%
Americas, excluding US Revenue
10.06M9.35M6.62M
Americas, excluding US Revenue Growth
7.59%41.30%34.88%
Europe, Middle East, India, Africa Revenue
24.86M24.48M23.88M
Europe, Middle East, India, Africa Revenue Growth
1.54%2.50%4.70%
Asia Pacific and Other Revenue
8.45M8.01M8.66M
Asia Pacific and Other Revenue Growth
5.43%-7.48%20.04%
Revenue (Other)
1,000.00-8.00K-6.00K
Revenue (Total)
2.50B2.31B1.70B
Revenue (Total) Growth
8.45%35.90%56.75%

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13
Tests Processed
3.68M3.53M3.06M
Tests Processed Growth
4.49%15.04%22.78%
Tests Accessioned
3.63M3.47M3.00M
Tests Accessioned Growth
4.57%15.55%23.71%
Tests Reported
3.47M3.34M2.93M
Tests Reported Growth
3.81%14.22%22.54%
Tests Reported in Laboratory
3.42M3.29M2.87M
Tests Reported in Laboratory Growth
3.87%14.69%23.41%
Updated May 7, 2026. Data Source: Fiscal.ai.